Actively Recruiting
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Led by Dartmouth-Hitchcock Medical Center · Updated on 2025-11-21
125
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
Sponsors
D
Dartmouth-Hitchcock Medical Center
Lead Sponsor
C
Congressionally Directed Medical Research Programs
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden. Enrolling with a Caregiver is optional for CA participants. Investigators will compare two groups of CA participants and their Caregiver (enrolling with a Caregiver is optional): one who receives HOBSCOCTCH-CA immediately (Group 1) and another group that will receive HOBSCOTCH-CA (Group 2) after a 3-month waiting period. Participants will be in the study for about 6 months total. HOBSCOTCH-CA involves 45 to 60 minute one on one virtual sessions with a certified Cognitive Coach including a "pre" program session and 8 weekly sessions thereafter. Participants will learn about problem solving therapy and mindfulness or relaxation training. CA participants are asked to do short homework assignments and keep a brief daily diary on a smart phone app. All participants complete study questionnaires or surveys at enrollment, 3 months later and at 6 months (at the end of the study).
CONDITIONS
Official Title
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Service members, Veterans, or civilians diagnosed with brain cancer (excluding glioblastoma)
- Primary brain tumor with expected survival of 2 years or more confirmed by imaging and pathology
- Completed surgical and/or radiation therapy at least 3 months prior to enrollment
- Stable on all CNS-acting medications for at least one month before enrollment
- Experiencing subjective cognitive complaints
- Literate and proficient in English
- Access to the internet for pre-session and first session; telephone access for sessions 2-8
- Caregivers aged 18 or older caring for a brain cancer/tumor survivor with permission from the participant
- Caregivers literate in English with internet access for pre-session and session 1, and telephone access for session 8
You will not qualify if you...
- Diagnosis of neurodegenerative diseases such as Alzheimer's or Parkinson's disease
- Presence of acute psychiatric disorder or substance abuse
- Diagnosis of glioblastoma
- Caregivers with significant visual impairment preventing reading or writing
- Caregivers without reliable telephone or internet access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dartmouth-Health Lebanon
Lebanon, New Hampshire, United States, 03756
Actively Recruiting
Research Team
S
Sarah J. Kaden, BA
CONTACT
T
Trina K Dawson, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here